Functional assays have shown that the circ-EPHB4 levels decrease in HCC, which inhibits the occurrence, development, and metastasis of HCC by modulating the PI3K-AKT pathway and HIF-1α [43]. Here, EPHB4 is linked to hepatocellular carcinoma.